Triple therapy may stop Kids' Post-Surgery vomiting
NCT ID NCT01739985
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding a drug called droperidol to two standard anti-nausea medicines (ondansetron and dexamethasone) could better prevent vomiting after surgery in children at high risk. A total of 322 children aged 3 to 18 years took part. The main goal was to see if the three-drug combination reduced vomiting more effectively than the usual two-drug approach.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
322 people
The number who actually took part.
- Start date
-
Dec 2010
- Finished
-
May 2014
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
3 to 17 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children scheduled for surgery and with high risk of postoperative vomiting, i.e. with VPOP score up to 4 * Between 3 to 18 years * Informed consent signed or the owner (s) of parental * Children receiving a social security system Exclusion Criteria: * Ambulatory surgery * Preoperative corticosteroids * Postoperative sedation * Allergy known to droperidol, ondansetron or dexamethasone * Known hypokaliemia * Known hypomagnesemia * Bradycardia (\<55 bpm) * Congenital long QT syndrome * Treatment that induce prolonged QT * Pheochromocytoma * Severe depressive syndrome
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postoperative vomiting are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Necker Hospital
Paris, 75015, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.